93 3165 93 3165
Pill imprint 93 3165 93 3165 has been identified as Minocycline hydrochloride 50 mg.
Minocycline is used in the treatment of acne; rosacea; bacterial infection; skin and structure infection; skin infection (and more), and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy.
Minocycline 50 mg is not subject to the Controlled Substances Act.
See also related documents.
Minocycline hydrochloride Images
- Imprint:
-
93 3165
93 3165 - Strength:
- 50 mg
- Color:
- Pink
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- corn starch
magnesium stearate
gelatin
titanium dioxide
D&C Red No. 33
FD&C Red No. 3
FD&C Yellow No. 6
ferrosoferric oxide
shellac
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
propylene glycol
ammonia
- Drug Class:
- Tetracyclines
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-3165
More Minocycline Hydrochloride resources
- Minocycline
- Minocycline (Wolters Kluwer)
- Minocycline Capsules (Wolters Kluwer)
- Minocycline Extended-Release Tablets (Wolters Kluwer)
- Minocycline Injection (Wolters Kluwer)
- Minocycline Pellet-Filled Capsules (Wolters Kluwer)
- minocycline (Cerner Multum)
- Arestin eent (AHFS DI)
- Minocycline Hydrochloride (AHFS DI)
- Minocycline Hydrochloride eent (AHFS DI)
- Arestin (FDA)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
- Minocycline Tablets (FDA)
- Minocycline (Wolters Kluwer)


